📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
BAFNA PHARMACEUTICALS LIMITEDBAFNAPHPharmaceuticals
Open
118.44
High
118.44
Low
108.42
Close
109.34
Volume
1376
Exchange
nse
Time
30-Mar-2026

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Bafna Pharmaceuticals is  
Marubozu
Estimated Stoploss of Bafna Pharmaceuticals is ₹  
118.44
Bafna Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Bafna Pharmaceuticals has chances of  
Continuationℹ
 of the current trend. 

Trend

Bafna Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Bafna Pharmaceuticals is  
Downℹ
 by  

4.49

%. 
Target
Buy @ 

94.35

Sell @ 

145.13

Current @ 

109.34

Volume

The trade volumes of Bafna Pharmaceuticals have become  
Deficientℹ
The volume trend for Bafna Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Bafna Pharmaceuticals is  

Down

 by  

65.75

% 

Valuation

The current market price of Bafna Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 153cr and total assets worth ₹ 153cr, the balance sheet of Bafna Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Bafna Pharmaceuticals has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 2cr

. It is  
Upℹ
 by  

133.33

%. 

(*Mar 2025)

50% i.e. ₹ 22cr earned in operatingℹ
47.73% i.e. ₹ 21cr spent in investingℹ
2.27% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
Bafna Pharmaceuticals has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 6cr

. It is  
Downℹ
 by  

185.71

%. 

(*Mar 2024)

37.5% i.e. ₹ 9cr earned in operatingℹ
62.5% i.e. ₹ 15cr spent in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Bafna Pharmaceuticals is  

₹ 36cr

 and  

Profit

 is :  

₹ 3cr

(*Sep 2025)

Bafna Pharmaceuticals Profit is up by:  

0

% and Income is Up by:  

2.86

% 

(*Sep 2025)

The income of Bafna Pharmaceuticals is  

₹ 35cr

 and  

Profit

 is :  

₹ 3cr

(*Jun 2025)

Bafna Pharmaceuticals Profit is up by:  

200

% and Income is Down by:  

12.5

% 

(*Jun 2025)

The income of Bafna Pharmaceuticals is  

₹ 40cr

 and  

Profit

 is :  

₹ 1cr

(*Mar 2025)

Bafna Pharmaceuticals Profit is up by:  

100

% and Income is Up by:  

21.21

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.